TOP STORIES

• ACADEMIA Japanese Nephrology Society Publishes Recommendation on Use of HIF-PH Inhibitors
  October 2, 2020

• REGULATORY MHLW’s Review Division Head Stresses Evidence-Based Approval for Coronavirus Vaccines
  October 1, 2020

• REGULATORY Metformin Cancer Risk Acceptable at 1 in 550,000 Patients: NIHS Assessment
  October 1, 2020

• BUSINESS Torii Enjoys Stellar Performance from Corectim, 1st JAK Med for Atopic Dermatitis
  September 30, 2020

• BUSINESS Approval Now in Hand, CureApp Looks at Collaborations with Drug Makers to Push Therapeutic Apps
  September 29, 2020

• REGULATORY MHLW Approves Rakuten’s Photoimmunotherapy, Takeda’s PARP Inhibitor, Gilead’s Jyseleca and More
  September 28, 2020

• REGULATORY MHLW to Set Up Study Group to Investigate Formulary Initiatives at Hospitals: Pharmaceutical Management Director
  September 25, 2020

• BUSINESS LTL Pharma Looks to Acquire More Off-Patent Brands with Dellegra as a Catalyst
  September 24, 2020

• BUSINESS Avigan Hits Primary Goal for Novel Coronavirus, Filing Eyed in October: Fujifilm
  September 24, 2020

• BUSINESS Lucentis Biosimilar Filed in Japan; Senju/Gene Techno Eye 2021 Approval
  September 23, 2020

• REGULATORY Health Minister Vows to Gauge Impact on Medical Institutions in Discussing Off-Year Re-Pricing
  September 18, 2020

• REGULATORY New Japan PM Sticks to Abe’s Goal to Secure Coronavirus Vaccines for Whole Population by H1 2021
  September 17, 2020

• REGULATORY Ex-Health Minister Tamura Comes Back as MHLW Chief
  September 16, 2020

• REGULATORY Japan Inks COVAX Pact with Optional Arrangement, Commits 17.2 Billion Yen Upfront
  September 16, 2020

• BUSINESS Lilly Japan to Run Its First Voluntary Redundancy Program, 10% of Sales Force Targeted?
  September 15, 2020

• REGULATORY Japan to Officially Sign Up for COVAX Pact; Govt to Hammer Out Payment on Sept. 15
  September 14, 2020

• BUSINESS Nihon Chouzai’s Standard Formulary Service Expands to 17 Therapeutic Classes, Monitor Hospitals Moving to Craft Own Lists
  September 11, 2020

• REGULATORY Japan Scrambles to Collect Info on AstraZeneca Vaccine Trial Pause, Sticks to 2021 H1 Immunization Goal
  September 10, 2020

• COMMENTARY Sumitomo Dainippon Aims at 100 Billion Yen Sales from “Frontier Business,” Making Challenge Beyond Drugs
  September 9, 2020

• REGULATORY Sakigake Status Should Not Be Granted to Novartis Products until It Takes Prevention Measures for Approval Delay: Pharma Bureau Chief
  September 8, 2020

ページ

• « 先頭
• ‹ Prev
• …
• 100
• 101
• 102
• 103
• 104
• 105
• 106
• 107
• 108
• …
• Next ›
• 最終 »